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Abstract: 
Background: The steep, time-dependent loss of benefit from reperfusion in clinical trials is 
consistent with loss of penumbra over the early hours of ischaemia, as observed in animal 
models. Human imaging studies, however, show persistent penumbra for up to 48h. We 
investigated core and penumbra volumes and collateral status in relation to time after stroke 
onset within the first 6h.  
Methods: Using data from three multimodal CT-based studies in acute ischaemic stroke 
patients <6h after onset , we measured core and penumbra volumes, collateral status, and 
target mismatch (defined as core volume<50ml, perfusion lesion volume>15ml, mismatch 
ratio>1.8). Patients were grouped by onset to imaging time (<3, 3-4.5, 4.5-6h). We explored 
correlates of penumbra proportion by multivariable linear regression.  
Results: Analysis included 144 subjects. Across time epochs, neither proportions of 
penumbra (59%, 64%, 75% at <3, 3-4.5, >4.5h respectively, p=0.4) nor poor collaterals 
(15/56 (27%), 14/47 (30%), 4/15 (27%) at <3, 3-4.5, >4.5h, p=0.9) differed significantly. 
Penumbra proportion was not clearly related to time to imaging (R2=0.003; P= 0.5) but a 
trend for divergent effects by collateral status was seen (slight increase in penumbra over 
time with good collaterals versus reduced with poor, interaction p=0.08). The proportion of 
patients with target mismatch did not vary by time (56%, 74%, and 67% at <3, 3-4.5, >4.5h; 
p=0.09).  
Conclusions: In a cross-sectional sample imaged within 6h, neither the proportions of 
penumbral tissue nor “target mismatch” varied by time from onset. A trend for reducing 
penumbra proportion only among those with poor collaterals may have pathophysiological 
and therapeutic importance.   
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Introduction:  
The concept of the ischaemic penumbra segregates ischaemic brain tissue according to flow 
thresholds, penumbra being the tissue below the threshold for electrical failure, but above the 
threshold for energy failure and loss of neuronal integrity, which define ischaemic core (1, 2). 
Conventionally, core is believed to grow over time at the expense of penumbra, and is 
understood to be a consequence of the dynamic interaction of multiple factors including peri-
infarct spreading depressions and adverse neurochemical events (3). In animal models, 
transient MCA occlusion for 2-3 hours results in moderate to large infarct sizes reaching that 
of permanent MCA occlusion(4, 5), while on PET(6) and multi parametric imaging of protein 
and ATP synthesis(7), penumbra was almost absent 6-8 hours after permanent MCA 
occlusion .  
Consistent with animal data on penumbra decline, the probability of favourable clinical 
outcome declines rapidly with increasing onset-to-treatment or onset-to-reperfusion time for 
both IV Thrombolysis (8) and endovascular reperfusion(9) within the first 6-8 hours after 
symptom onset. Although unproven, the concept of “collateral failure” and consequent 
penumbral loss as a function of duration of ischaemia has been suggested as a possible 
explanatory factor for this time dependence (10).  
Clinical imaging observations are, however, not uniformly consistent with this explanation. 
Several human studies show persistence of imaging features accepted as consistent with 
penumbra for much longer across modalities including PET(11) , MRI perfusion-diffusion 
mismatch (12) and for time periods of up to 48h.  Using Xenon CT within 6 hours of MCA 
occlusion, penumbra represented a constant proportion of MCA territory (32±7%; range, 
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16.2% to 46.9%) while the proportion of core showed wide inter-individual variation 
(37.6%±18.7%; range, 7.6% to 70.5%), (13). In proximal arterial occlusion, good collaterals 
were associated with both favourable tissue and clinical outcomes, while time from onset was 
unrelated to either collateral grade or mismatch proportion (14). In patients treated with 
endovascular therapy, the interaction of good collaterals and reperfusion, but not time from 
symptom onset to reperfusion, influenced penumbral tissue loss (15). 
We investigated the relationship of penumbra volume, collateral status and their interaction 
over time within 6 hours of stroke onset. 
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Methods: Subjects were recruited at a single centre for one of three multimodal imaging 
studies undertaken between 2008 and 2013(16, 17). Two were observational studies and one 
was a clinical trial comparing two thrombolytic agents. In the two observational studies  (one 
investigating feasibility of complex imaging, one investigating pathophysiology of acute 
hyperglycaemia), all ischemic stroke patients aged above 18 years and presenting up to 6 
hours after symptom onset were eligible. In the clinical trial, patients eligible for 
thrombolysis within 4.5 hrs were randomised to receive either alteplase or tenecteplase. 
Patients were excluded if they had contraindications to contrast administration (history of 
allergy or estimated Glomerular Filtration Rate <30ml/min). In all studies, acute ischaemic 
stroke patients underwent non-contrast CT (NCCT), CT angiography (CTA) and CT 
perfusion (CTP) imaging at baseline (<6h after onset) with follow-up brain imaging with CT 
at approximately 24h after recruitment, and repeat CTA if occlusion was present on baseline 
imaging. Clinical outcome was evaluated at 30 days or 3 months.   
For this analysis, we selected subjects with a perfusion lesion and anterior territory arterial 
occlusion (ICA, M1, M2, or M3).   
Imaging acquisition: 
All scans were performed on a Philips Brilliance 64 multidetector scanner. Whole brain 
NCCT was acquired first, (5 mm slice thickness FOV 218 x 218 mm, 120 kv, 171 mA or 0·9 
mm slice thickness, FOV 250x250  mm, 120 kV, 404 mA) followed by CTP with 40 mm slab 
coverage from the basal ganglia (8x5 mm slices, FOV 25 cm, 80 kVp, 476 mA, 2 second 
cycle time, 30 cycles) using a 50 ml contrast bolus administered at 5 mls per second (350 
Xenetix) via a large-gauge cannula. A CTA covering aortic arch to the top of the lateral 
ventricles (0·67 mm slice thickness, 120 kV, 475 mA) was acquired during the first arterial 
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past of contrast (Xenetix 350, 60 ml, followed by 30 ml of saline bolus, both given at 5 ml 
per second). 
Imaging processing and analysis: 
Imaging studies were anonymised, and analysed independently by two research fellows (BC, 
XH). CT perfusion was processed offline using MiStar (Apollo Medical Imaging 
Technology, Melbourne, Australia). Deconvolution of tissue enhancement curves and arterial 
input function (AIF) selected from the anterior cerebral artery was performed using modified 
singular value decomposition (SVD) with compensation for the effects of arterial delay and 
dispersion. Delay time (DT) was determined by a delay corrected SVD deconvolution by 
applying a series of delay time (DT) values, with actual delay time being minimum DT value, 
which produces Tmax=0(18). Cerebral Blood Flow (CBF) and Cerebral Blood Volume 
(CBV) were calculated from the peak height and area under tissue enhancement curves 
respectively, and Mean Transit Time (MTT) = CBV/CBF.  
Penumbra definitions: 
Ischaemic core was defined as tissue with reduced CBF (relative CBF <40% of contralesional 
hemisphere) and prolonged delay time (relative DT >2 sec); penumbra volume was defined 
as tissue with relative DT >2 sec but relative CBF ≥ 40% of contralateral (19). We used 
Relative penumbral volume (%, penumbra volume/ total ischemic lesion volume) 100) 
throughout this paper. 
 
Collateral scores: 
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If retrograde flow was seen on CTP, collaterals were graded on CTA qualitatively (14). We 
defined collaterals as good (angiographic flow distal to occlusion), moderate (angiographic 
flow to ischemic territory but not distal to occlusion), or poor (contrast opacification only in 
distal superficial branches). We used a modified Miteff’s classification to incorporate 
terminal ICA, M1 and M2 occlusion, whereas the original classification excluded M2 
occlusion (14). 
 
Target mismatch:  
Target mismatch was defined as a perfusion lesion >15 ml with core volume < 50 ml and 
mismatch between perfusion lesion and core >1.8(20) . To account for the limited z axis 
coverage of CTP, we reduced the 70ml threshold used by EXTEND-IA(21) and DEFUSE-
2(20)  proportionately, by dividing the mean of (Coregistered Infarct volume over 4cm/Total 
Infarct volume from whole brain NCCT) in the non-recanalised group. This figure was 0.7 
(i.e.  Approximately 70% of total infarct is in the 4 cm slab covered by CTP). This was 
multiplied by 70ml, to yield an adjusted volume of 50ml to define target mismatch. 
Statistical analysis: 
We compared the groups across 3 time epochs: <180, 180-270, and >270 min from stroke 
symptom onset to CTP acquisition time. We used chi-square or Fisher’s tests for categorical 
variables and Mann-Whitney tests for continuous variables. We conducted linear regression 
for the prediction of penumbra proportion. We used IBM SPSS Statistics 22 version for all 
the statistical analysis.  
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Results: 
From a total of 263 subjects, 180 had a visible perfusion lesion on perfusion imaging, 147 of 
whom had anterior territory occlusion (ICA=40, M1=60, M2= 39, M3= 8); CTP was 
available in 144 subjects, who constituted the main analysis population. Collateral assessment 
was possible in 118 with retrograde flow on CTP-SI, who constituted the population analysed 
for relationship to collaterals (Figure 1). 28 patients with anterograde flow distally from 
occlusion were excluded from collateral grading as they would not represent true collateral 
circulation. In the main analysis group, the overall population had median age 74 years (IQR 
63-81) and median NIHSS 15(10-20). On initial imaging, median ASPECT score was 7 (5-9), 
median core volume 23ml (IQR 11-48), and median penumbra volume 42 ml (IQR 25-65). 
Occlusion was present in the ICA (or tandem) in 39 (27%), MCA M1 segment in 59 (41%), 
M2 in 38 (26%), and M3 in 8 (5%).  Baseline characteristics in the subgroup of 118 with 
assessable collateral status did not differ from the overall study population.  
Baseline clinical and imaging characteristics across time epochs (<3, 3-4.5, >4.5 h) are 
detailed in Table 1.There were no significant differences in baseline characteristics. Across 
time epochs, neither relative penumbra volume (59%, 64%, 75%  at <3, 3-4.5, >4.5h 
respectively, p=0.4; Figure 2), absolute penumbra volumes ( 41(22-58), 46 (32-69), 40 (26-
76) at <3, 3-4.5, >4.5 h respectively, p=0.3; Figure 2), target mismatch (56%, 74%, 67% at 
<3, 3-4.5, >4.5 h respectively, p=0.09; Figure 2), nor poor collaterals (15/56 (27%), 14/47 
(30%), 4/15 (27%) at <3, 3-4.5, >4.5h, p=0.9; Figure 2) differed significantly. 
 
Median penumbra proportion was 45% with poor collaterals versus 72% with good or 
moderate collaterals (P<0.001); relative penumbra volume was not clearly related to time to 
8 
 
imaging (R2=0.003, p= 0.5; Figure 3) but a trend for divergent effects by collateral status was 
seen (slight increase in penumbra over time with good or moderate collaterals versus reduced 
with poor, R2=0.03 for both; p=0.08; Figure 3). In univariate linear regression, potentially 
significant variables predicting proportion of relative penumbra volume (p <0.1) were: large 
artery (ICA or M1) occlusion, good or moderate collaterals, time to CTP*good or moderate v 
poor collaterals, diabetes and NIHSS.  Age, time to CTP, systolic blood pressure   and blood 
glucose were not significant predictors of Penumbra proportion (Table 2). In multivariate 
linear regression, NIHSS, good or moderate collaterals versus poor collaterals remained 
independently significant predictors of penumbra proportion (Table3). 
 
 
We analysed a sub-group of ICA and M1 occlusion patients (n=100) to explore whether the 
lack of variability in penumbra proportion also holds true in a more homogeneous group. 
Relative penumbra volume was not clearly related to time to imaging (R2=0.009; p= 0.3. 
supplementary data figure I), but a trend for divergent effects by collateral status was again 
seen (slight increase in penumbra over time with good collaterals versus reduced with 
moderate or poor, R2=0.04 for both; p=0.09. Supplementary data figure II). 
 
Discussion: 
 
Our findings in this cross-sectional study population are consistent with previous reports 
showing persistence of an imaging-defined penumbra in humans, with no evidence of 
penumbral decline that could explain the time-dependence of therapeutic benefit from 
reperfusion therapy within the first 6h after stroke onset(13).  This was the case regardless of 
whether penumbra was assessed by absolute volume, volume relative to core, the proportion 
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of patients with “target mismatch”, or the presence of favourable collateral flow patterns. The 
sustained presence of penumbra on imaging in human studies contradicts the assumption that 
the short effective time window for clinical benefit from reperfusion can be explained by  
steep, time dependent, penumbral decline within first few hours from onset as observed in 
animal models(1, 9, 22).  
 
 
Our main observation of interest was a potential divergent effect of penumbral proportion 
over time according to collateral status, with lower proportions of penumbra in later times 
being seen only among those with poor collateral flow. This observation challenges the 
concept of “collateral failure” as a general mechanism driving the loss of penumbral tissue 
over time (10), and instead suggests that the collateral status at initial presentation may define 
a group with a different natural history and much shorter time to intervene. A larger study 
will be needed to investigate these further (In our study, the results suggest a trend with a p 
value =0.08). These observations are consistent with previous studies. Bang and colleagues 
(23) studied the interaction of collaterals and perfusion-diffusion mismatch (perfusion lesion 
defined as Tmax ≥4 s) and found that neither collateral grading, nor mismatch lesion volumes 
correlated with time. Poor collaterals were independently correlated with larger infarct 
growth. Jung and colleagues, in 44 subjects with M1 or M2 occlusion undergoing 
endovascular therapy within 6 hours and resulting in at least partial reperfusion, showed that 
elapsed time accounted for only a minor proportion of penumbra tissue (defined as Tmax≥6s) 
loss in good collateral grades but a larger proportion in poor collateral grades (15). 
 
A wide variety of methods for collateral assessment have been proposed,(24) and only 
limited study of the consistency of these competing approaches has been undertaken. The 
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approach used here, modified from that of Miteff,(14) requires time-resolved vessel imaging, 
and may be closer to the multiphasic CTA approach developed by Goyal and colleagues and 
deployed in the majority of patients recruited to the ESCAPE trial (25). Whether single-phase 
CTA would yield equivalent findings in clinical use is unclear, and in addition, all of these 
collateral assessment methods are confined to occlusions of the terminal ICA or proximal 
MCA. Validation using other methods of collateral assessment and in other vascular 
territories will be important.  
 
Our conclusions are limited by the limited number of subjects, particularly after 4.5 hours 
from symptom onset, and the limited range of onset-to-imaging times that were covered in 
our dataset. To our knowledge, this is the first CT perfusion study assessing the association of 
penumbra volume with time and our patient cohort is larger than MRI based studies reported 
previously (15). Since CTP has important practical advantages over MRI, it has become more 
widely used in patient selection protocols, especially for recent endovascular trials, and 
characterisation of the relationships between perfusion characteristics and collaterals for this 
modality are therefore important. We used validated thresholds (18, 26) for core and 
penumbra, but thresholds for CT perfusion are not uniform, and their derivation is based on 
limited numbers(27). In common with the majority of imaging studies, we have to infer the 
persistence of a presumed time-dependent imaging appearance from cross-sectional data 
rather than sequential imaging in each patient. Repeated imaging studies in the acute stroke 
population are logistically extremely difficult since patient care may be compromised, and in 
addition, radiation and contrast exposure limit the repeatability of CTP.  Our CT scanner had 
restricted brain parenchyma coverage of 4 cm on a single acquisition, requiring us to modify 
the definitions of “target mismatch” based on whole brain volumes in large detector CTP(21) 
or MRI studies for this more restricted brain coverage, but the 50ml core volume criterion, 
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while obtained by the ratio of 4cm coverage volume to whole brain volume, has not been 
validated independently. It is possible that larger volume acquisition, either by undertaking 
two examinations for contiguous 4cm slabs, or with larger detector scanners, might disclose a 
different relationship from that demonstrated here, since this may improve coverage of 
anatomically marginal brain regions omitted by a protocol centred predominantly on the basal 
ganglia. It is also possible that the limited time period covered may disguise relationships 
between collaterals and penumbra that become evident over longer observation periods(10). 
Our purpose, however, was to explore the potential relevance of these MRI-defined 
phenomena over the time scale relevant to early intravenous or endovascular therapy. 
 
In conclusion, we found no decrease in the proportion of CTP-defined penumbral perfusion 
within perfusion lesions, or the proportion of patients with target mismatch or favourable 
collateral patterns within the first 6 hours after stroke onset. A decline in proportion of 
penumbra with time was restricted to those with poor collateral status. It is therefore possible 
that collateral flow grade, rather than time since onset, might define suitability for reperfusion 
therapies. This may be relevant in identifying patients from unknown onset, wakeup stroke 
population for thrombolysis. Given the strong effect of time on outcomes after reperfusion 
treatment, further investigations into the interaction between collaterals, penumbra and time 
is required 
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 Supplementary material:   
 
Figure1. Study CONSORT chart 
 
 
 
Excluded (n=33): 
a)posterior territory occlusion (n=12) 
b) no occlusion (n=20) 
c) not available (n=1) 
 Anterior territory occlusion 
(n=147) 
 
Excluded time to CTP unavailable 
(n=3) 
Subgroup with collateral grading 
available (n=118) 
 
Excluded no retrograde flow on 
CTP (n=29) 
 
Suitable for penumbral proportion 
comparison across time epochs (n=144) 
 
Assessed for site of occlusion (n=180) 
Total subjects from 3 
studies (n=263) 
Excluded without a perfusion 
lesion (n=83) 
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Figure 2.  Relative (Panel A), absolute (Panel B) Core, penumbra volumes and collateral 
grades (Panel C) across time epochs. 
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Figure.3. Penumbra relationship with time alone (Panel A) & interaction of collaterals with  
time (Panel B). 
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Table1. Baseline characteristics of study population (n=144) 
 Time to CT Perfusion (in minutes) 
0-180 
min(n=71) 
181-270 
min(n=58) 
>270min(n=15) p value 
Female (n, %) 28 (39.4%) 32 (55%) 5 (33%) 0.1 
Right side ischemia (n, 
%) 
32(46%) 32 (55%) 7 (47%) 0.55 
Age, years (median, 
IQR) 
72(62-79) 76(70-81) 71(61-80) 0.053 
NIHSS (median, IQR) 16(9-21) 14(10-19) 14.5(6.75-19) 0.34 
ASPECT score (median, 
IQR) 
7(5-9) 7(5-9) 6(5-7) 0.6 
ASPECT score 0-4 11(15%) 11(19%) 1(7%) 0.1 
ASPECT score 5-7 35(48%) 20(35%) 11(73%)  
ASPECT score 8-10 26(36%) 27(47%) 3(20%)  
Glucose 
(mmol/l)(median, IQR) 
6.6(5.7-8.2) 6.8(5.6-8.2) 5.9(5.3-6.7) 0.3 
Systolic Blood Pressure 
mmHg (median, IQR 
143(135-162) 149(137-171) 142(131-160) 0.5 
Previous Stroke or TIA 
(n,%) 
12/71(17%) 17/57(30%) 3/14(21.4%) 0.22 
Atrial fibrillation (n, %) 29 (42%) 25 (47%) 3 (21%) 0.22 
Diabetes 9 (13%) 6 (10%) 1(6.7%) 0.77 
Hypertension (n, %) 43 (61%) 34 (58.6%) 8 (53%) 0.8 
Hyperlipidemia (n, %) 36 (51%) 29 (50%) 9 (60%) 0.77 
 Site of vessel 
occlusion 
    
 
 
ICA/tandem 
occlusion (n, %) 
19 (27%) 16 (27.6%) 4 (26/7%) 0.9 
 M1 (n, %) * 26 (36.6%) 26 (45%) 7 (47%)  
 M2 (n, %) * 21 (29.6%) 14 (24%) 3 (20%)  
 M3 (n, %)* 5 (7%) 2 (4%) 1 (6.7%)  
Core 
volume(ml)(Median, 
IQR) 
26 (11.5-49.5) 23 (14-48) 15 (11-38) 0.7 
Penumbra 
volume(ml)(Median, 
IQR) 
41 (22.5-58) 46 (32-69) 40 (26-76) 0.3 
 Relative core volume) 
(%) † 
41 (21-58) 36 (22-50) 25 (17-61) 0.4 
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Relative penumbra 
volume (%) † 
59 (41-79) 64 (50-78) 75 (39-82) 0.4 
penumbra/core ratio 
(Median, IQR)  
1.45(0.6-3.6) 1.8(1-3.6) 3(0.6-4.7) 0.3 
Target mismatch (n, %) 39/70 (56%) 43/58 (74%) 10/15 (67%) 0.09 
Good collaterals (n, %) 22/56 (39%) 17/47 (36%) 7/15 (47%) 0.9§ 
Moderate collaterals (n, 
%) 
19/56 (34%) 16/47 (34%) 4/15 (27%)  
Poor collaterals (n, %) 15/56 (27%) 14/47 (30%) 4/15 (27%)  
NIHSS: National Institute of Health Stroke Scale; ASPECTS: Alberta Stroke Program Early 
CT score; TIA: Transient Ischemic Attack; ICA: Internal Carotid artery; * Middle Cerebral 
Artery M1, M2, M3 segments; † proportion (%) of core, penumbra volume(s) in total 
perfusion lesion volume (core or penumbra volume/ total perfusion lesion volume) 100). § p 
value is for a chi-squared analysis of the distribution across all 3 categories. 
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Table 2.Univariate linear regression for predictors of relative penumbra volume *  
variable Β coefficient (95% CI) P value 
ICA or M1 occlusion -7(-14-0.4) 0.06 
Time to CTP 0.2(-0.3-0.07) 0.5 
(Good or moderate) versus 
poor collaterals 
22(14-29) <0.01 
Time* ((good or moderate) v 
poor collaterals) 
0.089 (-0.012-(0.2)) 0.08 
Diabetes -11.37(-22-(-0.3)) 0.043 
NIHSS -1.5(-1.9-(-1.05)) <0.01 
Age 0.034((-0.28)-0.34) 0.8 
Blood glucose -0.75((-0.18)-0.37) 0.18 
Systolic blood pressure -0.089((-0.25)-0.07) 0.2 
*Proportion of penumbra volume(s) in total perfusion lesion volume (penumbra volume/ total 
perfusion lesion volume) 100). 
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Table 3. Multivariate linear regression for predictors of relative penumbra volume * 
Variable Β Coefficient (95% CI) P value 
NIHSS -1.19(-1.6-(-0.5)) <0.01 
Good or moderate versus 
poor collaterals 
16(8.7-24) <0.001 
* Proportion of penumbra volume(s) in total perfusion lesion volume (penumbra volume/ total 
perfusion lesion volume) 100). 
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